Our Mission

Having fulfilled the promise of its first decade by advancing the understanding of the potential of stem cell biology, HSCI is now focused on bringing stem cell-based treatments to patients as quickly as possible. While continuing to advance scientific discovery, we are developing treatments for diseases of aging, the blood, metabolism, and neurological disorders. To accomplish this, we bring together more than 1,000 scientists in the schools and affiliated hospitals of Harvard, fund novel research, and implement new collaborative academic and industrial models.

Learn What HSCI is Doing For Diseases in These Research Groups:

Public Events

2016 Sep 26

HUBweek event: A Quantum Leap in Diabetes Treatment

8:30am to 10:00am


Harvard University, TBA

A part of the HUBweek series of events.

Hear from leading scientists, clinicians, and executives at HSCI and partner institutions who are working toward bringing stem cell-derived therapies to diabetic patients through the Boston Autologous Islet Replacement Therapy (BAIRT) Program.

Doug A. Melton, PhD
Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University
Co-Director, Harvard Stem Cell Institute
Scientific Founder, Semma Therapeutics